Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: Down-regulation of the angiogenesis-related genes ACVRL1 and EGFl7 in early-onset disease

Molecular Human Reproduction

Volumn 18, Issue 3, 2012, Pages 146-155

  Junus, K ^a   Centlow, M ^b   Wikstrm A K ^a   Larsson, I ^b   Hansson, S R ^b   Olovsson, M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Early onset pre eclampsia; Gene expression; Microarray; Placenta

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ANTIHYPERTENSIVE AGENT; EGF LIKE DOMAIN MULTIPLE 7 PROTEIN; FIBRONECTIN; GLOBIN; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; MESSENGER RNA; PROTEIN; ROUNDABOUT HOMOLOG 4 PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; DIMERIZATION; DOWN REGULATION; EARLY ONSET PREECLAMPSIA; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; LATE ONSET PREECLAMPSIA; NUCLEOTIDE SEQUENCE; OXYGEN TRANSPORT; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN DOMAIN;

ACTIVIN RECEPTORS, TYPE II; ADULT; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84857517106     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gar067     Document Type: Article

References (46)

1. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168:585-591.
2. Campagnolo L, Leahy A, Chitnis S, Koschnick S, Fitch MJ, Fallon JT, Loskutoff D, Taubman MB, Stuhlmann H. EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am J Pathol 2005;167:275-284.
3. Centlow M, Carninci P, Nemeth K, Mezey E, Brownstein M, Hansson SR. Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril 2008; 90:1834-1843.
4. Centlow M, Junus K, Nyström H, May K, Larsson I, Olsson MG, Akerström B, Sager R, Schneider H, Hansson SR. Perfusion of the human placenta with red blood cells and xanthine oxidase mimics preeclampsia in-vitro. Z Geburtshilfe Neonatol 2009;213:89-95.
5. Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 2008;282:120-129.
6. Cindrova-Davies T, Yung HW, Johns J, Spasic-Boskovic O, Korolchuk S, Jauniaux E, Burton GJ, Charnock-Jones DS. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 2007;171:1168-1179.
7. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003;4:P3.
8. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130-137.
9. Founds SA, Dorman JS, Conley YP. Microarray technology applied to the complex disorder of preeclampsia. J Obstet Gynecol Neonatal Nurs 2008; 37:146-157.
10. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 2003;12:817-828.
11. Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman JM, Kozhich OA, Larsson I, Marsal K, Medstrand P et al. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod 2006;12:169-179.
12. Helmestam M, Stavreus-Evers A, Olovsson M. Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro. Reprod Toxicol 2010; 30:370-376.
13. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
14. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970-975.
15. Jalili RB, Forouzandeh F, Bahar MA, Ghahary A. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation. Iran J Allergy Asthma Immunol 2007;6:167-179.
16. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-195.
17. Kudo Y, Boyd CA, Sargent IL, Redman CW. Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am J Obstet Gynecol 2003;188:719-726.
18. Lambert-Messerlian GM, Palomaki GE, Neveux LM, Chien E, Friedman A, Rosene-Montella K, Hayes M, Canick JA. Early onset preeclampsia and second trimester serum markers. Prenat Diagn 2009;29:1109-1117.
19. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683.
20. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-351.
21. Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 2005;26:601-607.
22. Mikheev AM, Nabekura T, Kaddoumi A, Bammler TK, Govindarajan R, Hebert MF, Unadkat JD. Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study. Reprod Sci 2008;15:866-877.
23. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, de Swiet M, Fletcher G, Jokinen M, Murphy D et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of preeclampsia in the community. Br Med J (Clin Res Ed) 2005;330:576-580.
24. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007;28:487-497.
25. Olsson MG, Centlow M, Rutardíttir S, Stenfors I, Larsson J, Hosseini-Maaf B, Olsson ML, Hansson SR, Åkerström B. Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger a1-microglobulin in preeclampsia. Free Radic Biol Med 2010;48:284-291.
26. Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 2004; 428:754-758.
27. Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30(Suppl A):S38-S42.
28. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl A):S32-S37.
29. Roten LT, Johnson MP, Forsmo S, Fitzpatrick E, Dyer TD, Brennecke SP, Blangero J, Moses EK, Austgulen R. Association between the candidate susceptibility ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur J Hum Genet 2009;17:250-257.
30. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF. Amplification efficiency: linking baseline and biasin the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37:e45.
31. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002;3:SOFTWARE0003.
32. Santoso DI, Rogers P, Wallace EM, Manuelpillai U, Walker D, Subakir SB. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. Placenta 2002;23:373-379.
33. Schmidt M, Paes K, De Maziere A, Smyczek T, Yang S, Gray A, French D, Kasman I, Klumperman J, Rice DS et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007;134:2913-2923.
34. Sitras V, Paulssen RH, Gronaas H, Vartun A, Acharya G. Gene expression profile in labouring and non-labouring human placenta near term. Mol Hum Reprod 2008;14:61-65.
35. Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, Vartun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta 2009;30:424-433.
36. Soncin F, Mattot V, Lionneton F, Spruyt N, Lepretre F, Begue A, Stehelin D. VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J 2003;22:5700-5711.
37. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001;184:1267-1272.
38. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121.
39. van Dijk M, van Bezu J, Poutsma A, Veerhuis R, Rozemuller AJ, Scheper W, Blankenstein MA, Oudejans CB. The pre-eclampsia gene STOX1 controls a conserved pathway in placenta and brain upregulated in late-onset Alzheimer's disease. J Alz Dis 2010; 19:673-679.
40. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004;111:298-302.
41. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
42. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143-148.
43. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368-1374.
44. Wikstrom AK, Larsson A, Akerud H, Olovsson M. Increased circulating levels of the antiangiogenic factor endostatin in earlyonset but not late-onset preeclampsia. Reprod Sci 2009a;16: 995-1000.
45. Wikstrom AK, Nash P, Eriksson UJ, Olovsson MH. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-I to PAI-II ratio in early-onset but not late-onset preeclampsia. Am J Obstet Gynecol 2009b;201:597.e1-e8.
46. Wyatt SM, Kraus FT, Roh C-R, Elchalal U, Nelson DM, Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005;26:372-379.